Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.

Gonnelli, S; Cadirni, A; Caffarelli, C; Petrioli, R; Montagnani, A; Franci, M B; Lucani, B; Francini, G; Nuti, R

Gonnelli, S; Cadirni, A; Caffarelli, C; Petrioli, R; Montagnani, A; Franci, M B; Lucani, B; Francini, G; Nuti, R.

Affiliation

Gonnelli S; Department of Internal Medicine, Endocrine-Metabolic Science and Biochemistry, University of Siena, Policlinico Le Scotte, Viale Bracci 2, 53100 Siena, Italy. gonnelli@unisi.it

Bone ; 40(1): 205-10, 2007 Jan.

Article in En | MEDLINE | ID: mdl-16904960

Subject(s)

Androstadienes/adverse effects; Aromatase Inhibitors/adverse effects; Bone Remodeling/drug effects; Bone Resorption/chemically induced; Breast Neoplasms/drug therapy; Alkaline Phosphatase/blood; Androstadienes/therapeutic use; Aromatase Inhibitors/therapeutic use; Biomarkers/blood; Bone Density/drug effects; Bone Resorption/diagnosis; Bone Resorption/prevention & control; Bone and Bones/diagnostic imaging; Collagen Type I/blood; Female; Humans; Middle Aged; Peptides/blood; Radiography; Tamoxifen/therapeutic use

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Bone Resorption / Breast Neoplasms / Bone Remodeling / Aromatase Inhibitors / Androstadienes Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links